United States - Re-Export of Alkaloids in Dosage Forms
Since 2014, United States Re-Export of Alkaloids in Dosage Forms decreased by 15.9% year on year. In 2019, the country was ranked number 2 among other countries in Re-Export of Alkaloids in Dosage Forms at $5,631,866.19. Italy topped the ranking with $85,194,681.49 in 2019, a fall of 13.8% compared to 2018. Canada witnessed the best average annual growth at +76.7% per year, while Saudi Arabia witnessed the worst performance at -37.7% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 5,631,866.19 |
| 2018 | 5,381,393.00 |
| 2017 | 6,178,766.00 |
| 2016 | 6,886,767.00 |
| 2015 | 9,310,766.00 |
Download all data from 1991 to 2019
How does United States rank in Re-Export of Alkaloids in Dosage Forms?
| # | 17 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Italy
|
85,194,681.49 | 2019 | -13.8 % | +5.8 % | View data |
| 2 |
#2
United States
|
5,631,866.19 | 2019 | +4.7 % | -15.9 % | View data |
| 3 |
#3
United Arab Emirates
|
4,857,182.74 | 2019 | -27.3 % | +50.5 % | View data |
| 4 |
#4
Canada
|
1,855,430.25 | 2019 | +10.7 % | +76.7 % | View data |
| 5 |
#5
Georgia
|
1,537,048.50 | 2019 | -18.8 % | -1.2 % | View data |